APA (7th ed.) Citation

SU, N., I, R., A, K., AU, H., I, H., MS, K., . . . MU, R. (2026). Peptide-based therapeutics in the management of Alzheimer's disease (AD) and their potential to develop novel strategies. Metabolic brain disease, 41(1), . https://doi.org/10.1007/s11011-025-01781-w

Chicago Style (17th ed.) Citation

SU, Nabi, et al. "Peptide-based Therapeutics in the Management of Alzheimer's Disease (AD) and Their Potential to Develop Novel Strategies." Metabolic Brain Disease 41, no. 1 (2026). https://doi.org/10.1007/s11011-025-01781-w.

MLA (9th ed.) Citation

SU, Nabi, et al. "Peptide-based Therapeutics in the Management of Alzheimer's Disease (AD) and Their Potential to Develop Novel Strategies." Metabolic Brain Disease, vol. 41, no. 1, 2026, https://doi.org/10.1007/s11011-025-01781-w.